Dissociation between serum interleukin-6 rise and other parameters of disease activity in subacute thyroiditis during treatment with corticosteroid

Journal of Clinical Endocrinology and Metabolism

Volumn 81, Issue 2, 1996, Pages 577-579

  Yamada, Takashi ^a   Sato, Akira ^b   Aizawa, Toru ^c  

^a Kashiwa Municipal Hospital   (Japan)

^b DOKKYO MEDICAL UNIVERSITY   (Japan)

^c SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; C REACTIVE PROTEIN; CORTICOSTEROID; INTERLEUKIN 6; PREDNISOLONE; THYROGLOBULIN; THYROXINE;

ADULT; ARTICLE; AUTOIMMUNITY; CLINICAL ARTICLE; CORTICOSTEROID THERAPY; DISEASE ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; ERYTHROCYTE SEDIMENTATION RATE; ETIOLOGY; FEMALE; HUMAN; IMMUNOMODULATION; INFLAMMATORY DISEASE; PRIORITY JOURNAL; SUBACUTE THYROIDITIS;

ADRENAL CORTEX HORMONES; ADULT; BLOOD SEDIMENTATION; C-REACTIVE PROTEIN; FEMALE; HUMANS; INTERLEUKIN-6; KINETICS; MIDDLE AGED; PREDNISOLONE; THYROGLOBULIN; THYROIDITIS, SUBACUTE; THYROXINE;

EID: 0030063401     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.81.2.577     Document Type: Article

References (15)

1. Heinrich PC, Castell JV, Andus T. 1990 Interleukin-6, the acute phase response. Biochem J. 265:621-636.
2. Hirano T. 1994 Interleukin-6. In: Thomson AW, ed. The cytokine handbook, 2nd ed. New York: Academic Press; 145-168.
3. Bartalena L, Farsetti A, Flink IL, Robbins J. 1992 Effects of interleukin-6 on the expression of thyroid hormone-binding protein genes in cultured human hepatoblastoma-derived (Hep G2) cells. Mol Endocrinol. 6:935-942.
4. Bartalena L, Hammond GL, Farsetti A, Flink IL, Robbins J. 1993 Interleukin-6 inhibits corticosteroid-binding globulin synthesis by human hepatoblastomaderived (Hep G2) cells. Endocrinology. 133:291-296.
5. Grubeck-Loebenstein B, Buchan G, Chantry D, et al. 1989 Analysis of intrathyroidal cytokine production in thyroid autoimmune disease: thyroid follicular cells produce interleukin-1α and interleukin-6. Clin Exp Immunol. 77:324-330.
6. Weetman AP, Bright-Thomas R, Freeman M. 1990 Regulation of interleukin-6 release by human thyrocytes. J Endocrinol. 127:357-361.
7. Iwamoto M, Sakihama T, Kimura N, Tasaka K, Onaya T. 1991 Augmented interleukin-6 production by rat thyrocytes (FRTL 5): effects of interleukin-β and thyroid stimulating hormone. Cytokine. 3:345-349.
8. 4-binding globulin concentration. J Endocrinol Invest. 16:213-216.
9. Bartalena L, Brogioni S, Grasso L, Rago T, et al. 1994 Interleukin-6: a mark of thyroid- destructive processes? J Clin Endocrinol Metab. 79:1424-1427.
10. Murakami M, Koizumi Y, Aizawa T, et al. 1988 Studies of thyroid function and immune parameters in patients with hyperthyroid Graves' disease in remission. J Clin Endocrinol Metab. 66:103-108.
11. Aizawa T, Ishihara M, Koizumi Y, et al. 1990 Serum thyroglobulin concentration as an indicator for assessing thyroid stimulation in patients with Graves' disease during antithyroid drug therapy. Am J Med. 89:175-180.
12. Ida N, Sakurai S, Hosaka T, et al. 1990 An enzyme-linked immunosorbent assay for the measurement of human interleukin-6. J Immunol Methods. 133: 279-284.
13. Castell JV, Geiger T, Gross V, et al. 1988 Plasma clearance, organ distribution and target cells of interleukin-6/hepatocyte-stimulating factor in the rat. Eur J Biochem. 177:357-361.
14. Nikolai TF. 1991 Silent thyroiditis and subacute thyroiditis. In: Braverman LE, Utigar RD eds. The thyroid, 6th ed. New York: Lippincott; 710-727.
15. Strakosch CR, Joyner D, Wall JR. 1978 Thyroid-stimulating antibodies in patients with subacute thyroiditis. J Clin Endocrinol Metab. 46:345-348.